주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Special
목록
(
총 :
147 )
기사목록 보기 형태
제목형
요약형
포토형
[Top K-Pharma Analysis ⑭] Medytox's market cap doubles in 4 months
Lee Han-soo
2023.06.01 10:08
[Botulinum Toxin Trends] Something borrowed, something blue, and a shot of BTX?
Marianne Chang
2023.06.01 09:39
[Special] Dong-A ST speeds up global entry with new drugs
Kim Chan-hyuk
2023.05.31 14:51
Are in silico modeling and organoids poised to replace animal testing in pharma?
Marianne Chang
2023.05.30 17:02
Samsung Biologics to participate in 2023 BIO International Convention
Lee Han-soo
2023.05.30 15:16
Science and safety behind Merz's 'beauty'
Park Gi-taek
2023.05.25 16:26
Prestige Biopharma to attend BIO 2023
Kim Chan-hyuk
2023.05.25 16:01
Continuous manufacturing: a dream or reality for Korean biopharma?
Marianne Chang
2023.05.25 13:45
CHA Biomedical Group seeks global biz expansion at BIO 2023
Kim Chan-hyuk
2023.05.25 11:31
[Top K-Pharma Analysis ⑬] Caregen bullish on 2023 sales, targets more than double growth
Lee Han-soo
2023.05.24 15:39
[Special] Korean CDMO companies ready to wheel and deal at BIO 2023
Lee Han-soo
2023.05.23 17:20
[Special] Which Korean companies will be most active at BIO 2023?
Kim Chan-hyuk
2023.05.23 13:34
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기